In 2023, the mortality rate for Parkinson's Disease among women in the U.S. was positioned below 11.5 female deaths per hundred thousand. Over the next few years (2024-2028), a consistent year-on-year increase is forecasted, peaking at 13.9 by 2028. The yearly growth rates highlight an upward trajectory in mortality.
- 2024: 5.2% increase
- 2025: 5.2% increase
- 2026: 5% increase
- 2027: 4.7% increase
- 2028: 4.5% increase
The compound annual growth rate (CAGR) from 2024-2028 suggests an average annual increase, reflecting a consistent rise in mortality due to Parkinson's Disease. Future trends to watch for include advances in treatment that could potentially slow this increase, demographic shifts affecting the elderly population, and innovations in early detection methods which could alter mortality forecasts substantially.
